Human recombinant lipocortin 1 inhibits prostacyclin production by human umbilical artery in vitro.
Submicromolar concentrations of human recombinant Lipocortin 1 inhibit the release of prostacyclin from human umbilical artery rings in a dose-dependent fashion. This is the first demonstration that the recombinant protein is effective in human cells.